DNDN STOCK

Related Searches : DNDN STOCK, DENDREON, DNDN, BP STOCK, PROVENGE, XOM

Shares of Dendreon Corp. (DNDN) have been halted and the company just announced they have received FDA Approval for Provenge. FDA clears Dendreon's prostate cancer vaccine. Before the stock halt, Dendreon's stock traded above $45 per ...
The Market Guardian The Food and Drug Administration Thursday approved a new type of prostate cancer treatment from Dendreon Corp. The therapy, Provenge, is approved for certain men with advanced prostate cancer who have failed ...
Update: DNDN stock has halted up 14+%. There are 13 million shorts who are getting their faces ripped off. Dendreon Corporation (Nasdaq: DNDN) today announced that the U.S. Food and Drug Administration (FDA) has approved PROVENGE(R) ...

Dndn_Stock in WIKIPEDIA